Answers are grounded in this paper and cite their sources.
The use of alternative donor stem cell sources can expand the number of patients able to receive allogeneic therapy. Preliminary studies indicate that the use of alternative donors can provide reliable engraftment, although graft-vs-host disease remains a concern.
No takes yet. Share an insight, caveat, or question.
Goggins et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: